中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb

文献类型:期刊论文

作者Xin Zhao1; Xiao-Xu Yang2; Su-Zhen Ji1; Xiao-Zeng Wang1; Li Wang1; Chong-Huai Gu1; Li-Li Ren1; Ya-Ling Han1
刊名Military Medical Research
出版日期2016
卷号3期号:1
ISSN号2054-9369
其他题名Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb
英文摘要In worldwide, the mortality rate of acute myocardial infarction (AMI) raises year by year. Although the applications of percutaneous coronary intervention (PCI) and anticoagulants effectively reduce the mortality of patients with acute coronary syndrome (ACS), but also increase the incidence of bleeding. Therefore, drugs with stable anticoagulant effects are urgently required.
语种英语
源URL[http://ir.imr.ac.cn/handle/321006/159370]  
专题金属研究所_中国科学院金属研究所
作者单位1.Institute of Metal Research, Chinese Academy of Sciences
2.沈阳医学院
推荐引用方式
GB/T 7714
Xin Zhao,Xiao-Xu Yang,Su-Zhen Ji,et al. Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb[J]. Military Medical Research,2016,3(1).
APA Xin Zhao.,Xiao-Xu Yang.,Su-Zhen Ji.,Xiao-Zeng Wang.,Li Wang.,...&Ya-Ling Han.(2016).Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb.Military Medical Research,3(1).
MLA Xin Zhao,et al."Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb".Military Medical Research 3.1(2016).

入库方式: OAI收割

来源:金属研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。